$14.57
-0.67[-4.40%]
Last update: 8:51AM Get Real Time Here
Range Cancer Therapeutics ETF (NASDAQ:CNCR), Quotes and News Summary
Range Cancer Therapeutics ETF (NASDAQ: CNCR) stock price, news, charts, stock research, profile.
| Open | $15.310 |
| High | $15.310 |
| 52 Wk High | 17.960 |
| Volume | 4.717K |
| Beta | - |
| P/E Ratio | - |
| Previous Close | - |
| Low | $15.111 |
| 52 Wk Low | 9.220 |
| Market Cap | - |
| Shares Out | - |
| P/B Ratio | - |
| Bid | $15.190 |
| Bid Size | 5 |
| VWAP | $15.310 |
| Ask | $15.300 |
| Ask Size | 6 |
| Exchange | XNAS |
| Dividend | - |
| Ex-Div Date | Dec 28, 2017 |
| Yield | - |
| Div. Freq | Annual |
FAQ
How do I buy Range Cancer Therapeutics ETF (CNCR) stock?
You can purchase shares of Range Cancer Therapeutics ETF (NASDAQ: CNCR) through any online brokerage.
Who are Range Cancer Therapeutics ETF's (CNCR) competitors?
There are no as such competitors for Range Cancer Therapeutics ETF.
What is the target price for Range Cancer Therapeutics ETF (CNCR) stock?
There is no analysis for Range Cancer Therapeutics ETF.
Current Stock Price for Range Cancer Therapeutics ETF (CNCR)?
The stock price for Range Cancer Therapeutics ETF (NASDAQ: CNCR) is $14.57 last updated May 1, 2024 at 8:51 AM EDT.
Does Range Cancer Therapeutics ETF (CNCR) pay a dividend?
A quarterly cash dividend of $0.35 per share of Class A Common Stock. The quarterly cash dividend was payable on January 2, 2018 to stockholders of record on December 28, 2017.
When is Range Cancer Therapeutics ETF (NASDAQ:CNCR) reporting earnings?
Range Cancer Therapeutics ETF does not have any upcoming earnings scheduled.
Is Range Cancer Therapeutics ETF (CNCR) going to split?
There is no upcoming split for Range Cancer Therapeutics ETF.